Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

FDA Approval

Ravantage 45

CompanyHuvepharma, Inc (DUNS: 619153559)

Effective Date

April 1, 2025

Labeling Type

OTC TYPE A MEDICATED ARTICLE ANIMAL DRUG LABEL

Active Ingredients

Ractopamine(45.4 g in 0.45 kg)

Registrants (1)

Huvepharma EOOD

DUNS Number

552671651

Products (1)

Ravantage 45

NDC Product Code

23243-5278

Application Number

ANADA200768

Marketing Category

ANADA (C73583)

Route of Administration

ORAL

Effective Date

April 1, 2025

Ingredients

CASTOR OILInactive

Code: D5340Y2I9GClass: IACT

povidoneInactive

Code: FZ989GH94EClass: IACT

CORN COBInactive

Code: XXP8V4H4NYClass: IACT

RactopamineActive

Code: 309G9J93TPClass: ACTIBQuantity: 45.4 g in 0.45 kg

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy